NZ523785A - Pharmaceutical composition containing citalopram and method to make crystals of the citalopram salt with a median particle size of at least 40 microns - Google Patents

Pharmaceutical composition containing citalopram and method to make crystals of the citalopram salt with a median particle size of at least 40 microns

Info

Publication number
NZ523785A
NZ523785A NZ523785A NZ52378501A NZ523785A NZ 523785 A NZ523785 A NZ 523785A NZ 523785 A NZ523785 A NZ 523785A NZ 52378501 A NZ52378501 A NZ 52378501A NZ 523785 A NZ523785 A NZ 523785A
Authority
NZ
New Zealand
Prior art keywords
citalopram
crystals
range
unit dosage
dosage form
Prior art date
Application number
NZ523785A
Other languages
English (en)
Inventor
Ken Liljegren
Per Holm
Ole Nielsen
Sven Wagner
Original Assignee
H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ523785(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H filed Critical H
Publication of NZ523785A publication Critical patent/NZ523785A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ523785A 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram and method to make crystals of the citalopram salt with a median particle size of at least 40 microns NZ523785A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27
PCT/DK2001/000520 WO2001080619A2 (en) 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram

Publications (1)

Publication Number Publication Date
NZ523785A true NZ523785A (en) 2004-09-24

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ523785A NZ523785A (en) 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram and method to make crystals of the citalopram salt with a median particle size of at least 40 microns

Country Status (34)

Country Link
EP (1) EP1318805A2 (ru)
JP (1) JP2003531153A (ru)
KR (1) KR20030024833A (ru)
CN (1) CN1446089A (ru)
AR (1) AR030095A1 (ru)
AT (1) AT5744U1 (ru)
AU (2) AU2001100198B4 (ru)
BE (1) BE1013559A6 (ru)
BG (1) BG107578A (ru)
BR (1) BR0113250A (ru)
CA (1) CA2353693C (ru)
CH (2) CH694242A5 (ru)
CZ (1) CZ2003397A3 (ru)
DE (2) DE10139115A1 (ru)
EA (1) EA200300247A1 (ru)
ES (1) ES2172481B2 (ru)
FI (1) FI5176U1 (ru)
FR (1) FR2812811B1 (ru)
GB (1) GB2368014B (ru)
GR (1) GR1004193B (ru)
HR (1) HRP20030054A2 (ru)
HU (1) HUP0103071A3 (ru)
IE (1) IES20010693A2 (ru)
IL (1) IL154050A0 (ru)
IS (1) IS6021A (ru)
IT (1) ITMI20011637A1 (ru)
MX (1) MXPA03000837A (ru)
NL (1) NL1018741C1 (ru)
NO (1) NO20013891L (ru)
NZ (1) NZ523785A (ru)
PL (1) PL359824A1 (ru)
SK (1) SK2842003A3 (ru)
WO (1) WO2001080619A2 (ru)
YU (1) YU9003A (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
NZ540281A (en) * 2002-12-23 2008-07-31 Lundbeck & Co As H Escitalopram hydrobromide and a method for the preparation thereof
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
GB2446847B (en) * 2007-02-02 2012-02-22 Ubiquisys Ltd Location of Basestation
WO2017020841A1 (zh) * 2015-08-03 2017-02-09 深圳信立泰药业股份有限公司 一种含有lcz696的药物组合物及其制备方法
US20240100012A1 (en) * 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IS6021A (is) * 2000-08-10 2001-10-20 H. Lundbeck A/S Lyfjasamsetningar sem innihalda sítalópram

Also Published As

Publication number Publication date
ITMI20011637A1 (it) 2003-01-27
YU9003A (sh) 2006-05-25
DE10139115A1 (de) 2002-03-28
ITMI20011637A0 (it) 2001-07-27
HRP20030054A2 (en) 2005-02-28
GB0118579D0 (en) 2001-09-19
HUP0103071A2 (hu) 2002-05-29
CH694242A5 (de) 2004-10-15
AT5744U1 (de) 2002-11-25
GB2368014B (en) 2004-06-23
HUP0103071A3 (en) 2002-12-28
GB2368014A (en) 2002-04-24
AU2001100198A4 (en) 2001-08-16
NO20013891L (no) 2002-02-11
IES20010693A2 (en) 2002-07-10
BE1013559A6 (fr) 2002-03-05
FI5176U1 (fi) 2001-12-27
SK2842003A3 (en) 2003-09-11
PL359824A1 (en) 2004-09-06
FR2812811A1 (fr) 2002-02-15
MXPA03000837A (es) 2003-06-06
CA2353693C (en) 2003-07-22
ES2172481A1 (es) 2002-09-16
IS6021A (is) 2001-10-20
BG107578A (bg) 2003-09-30
DE20113195U1 (de) 2001-11-15
IL154050A0 (en) 2003-07-31
NO20013891D0 (no) 2001-08-09
NL1018741C1 (nl) 2002-02-12
KR20030024833A (ko) 2003-03-26
WO2001080619A3 (en) 2002-02-21
CZ2003397A3 (cs) 2003-06-18
CA2353693A1 (en) 2002-01-22
AR030095A1 (es) 2003-08-13
WO2001080619A2 (en) 2001-11-01
CH694241A5 (de) 2004-10-15
EA200300247A1 (ru) 2003-06-26
AU2001100198B4 (en) 2002-06-13
AU2001279591A1 (en) 2001-11-07
BR0113250A (pt) 2003-06-24
JP2003531153A (ja) 2003-10-21
HU0103071D0 (en) 2001-10-28
CN1446089A (zh) 2003-10-01
EP1318805A2 (en) 2003-06-18
ES2172481B2 (es) 2004-08-01
FR2812811B1 (fr) 2006-08-18
GR1004193B (el) 2003-03-24
GR20010100377A (el) 2002-09-06

Similar Documents

Publication Publication Date Title
EP1414435B1 (en) Crystalline composition containing escitalopram
AU2002355624A1 (en) Crystalline composition containing escitalopram
AU2001100198B4 (en) Pharmaceutical composition containing citalopram
CA2558198A1 (en) Crystalline composition containing escitalopram oxalate
US20030109577A1 (en) Pharmaceutical composition containing citalopram
US20030232881A1 (en) Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
GB2376233A (en) Crystals of a pharmaceutically acceptable salt of citalopram wherein the median particle size of the crystals is at least 40 microns
ZA200300561B (en) Pharmaceutical composition containing citalopram.
MXPA06009976A (en) Crystalline composition containing escitalopram oxalate

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)